TMTakahito Moriyama

Takahito Moriyama

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Takahito Moriyama has a total of 114 co-authors. Here are the top co-authors by number of shared publications:

  • Kosaku Nitta

    Department of Nephrology, Tokyo Women’s Medical University, 8-1 Kawada-Cho, Shinjuku-ku, 1628666, Tokyo, Japan 1

    31 shared publications
  • Keiko Uchida

    Department of Nephrology, Tokyo Women’s Medical University, 8-1 Kawada-Cho, Shinjuku-ku, 1628666, Tokyo, Japan 1

    25 shared publications
  • Takashi Takei

    Department of Medicine, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan

    17 shared publications
  • Mitsuyo Itabashi

    Department of Medicine, Kidney Center Tokyo Women's Medical University Tokyo Japan

    14 shared publications
  • Kazunori Karasawa

    Department of Nephrology, Tokyo Women’s Medical University, 8-1 Kawada-Cho, Shinjuku-ku, 1628666, Tokyo, Japan 1

    12 shared publications
  • Ayami Ochi

    Department of Medicine, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan

    9 shared publications

Latest Publications

  • Citric acid-based bicarbonate dialysate attenuates aortic arch calcification in maintenance hemodialysis patients: a retrospective observational study

    by Ken-Ichi Akiyama, Takahito Moriyama, Norio Hanafusa, Yutaka Miura, Momoko Seki, Yusuke Ushio, Kentaro Kawasoe, Yoei Miyabe, Kazunori Karasawa, Hidekazu Sugiura, et al.

    Background Progression of aortic calcification is associated with all-cause and cardiovascular mortality in hemodialysis patients. Blood calciprotein particle (CPP) levels are associated with coronary artery calcification and were reported to be inhibited when using citric acid-based bicarbonate dialysate (CD). Therefore, this study aimed to examine the effect of CD on the progression of the aortic arch calcification score (AoACS) and blood CPP levels in hemodialysis patients. Methods A 12-month retrospective observational study of 262 hemodialysis patients was conducted. AoACS was evaluated by calculating the number of calcifications in 16 segments of the aortic arch on chest X-ray (minimum score is 0; maximum score is 16 points). The patients were divided into the following groups according to their baseline AoACS: grade 0, AoACS = 0 points; grade 1, AoACS 1–4 points; grade 2, AoACS 5–8 points; grade 3, AoACS 9 points or higher. Patients on bisphosphonates or warfarin or with AoACS grade 3 were excluded. Progression, defined as ΔAoACS (12-month score – baseline score) > 0 points, was compared between the CD and acetic acid-based bicarbonate dialysate (AD) groups before and after adjusting the background using propensity score matching. Results The AoACS progression rate was significantly lower in the CD group than in the AD group (before matching: P = 0.020, after matching: P = 0.002). Multivariate logistic regression analysis showed that CD was significantly associated with AoACS progression (odds ratio 0.52, 95% confidence interval 0.29‒0.92, P = 0.025). Conclusion CD may slow the progression of vascular calcification in hemodialysis patients. Graphical abstract


  • Open Access

    A Novel Scoring System Based on Oxford Classification Indicating Steroid Therapy Use for IgA Nephropathy

    by Shusaku Itami, Takahito Moriyama, Yoei Miyabe, Kazunori Karasawa, Kosaku Nitta


  • Intracellular trafficking pathway of albumin in glomerular epithelial cells

    by Takahito Moriyama, Fumio Hasegawa, Yoei Miyabe, Kenichi Akiyama, Kazunori Karasawa, Keiko Uchida, Kosaku Nitta


  • Open Access

    Severity of arterial and/or arteriolar sclerosis in IgA nephropathy and the effects of renin–angiotensin system inhibitors on its prognosis

    by Naoko Sugiura, Takahito Moriyama, Yoei Miyabe, Kazunori Karasawa, Kosaku Nitta

    IgA nephropathy (IgAN) patients often suffer from arterial and/or arteriolar sclerosis (AAS); however, it is unclear whether these features are associated with a poor prognosis. This retrospective cohort study aimed to analyse the prognosis of IgAN patients with AAS and assess whether treatment with renin–angiotensin system inhibitors (RASI) improved their survival. The study included 678 IgAN patients, who were grouped into AAS0 (n = 340; AAS absent) and AAS1 (n = 338; AAS present) groups. Each patient's clinical, laboratory, and histological backgrounds and 20‐year renal prognosis were analysed. In the AAS1 group, the impact of RASI initiated during the follow‐up period on the renal prognosis was also evaluated after adjustments for background characteristics. IgAN patients with AAS had significantly higher age, blood pressure, body mass index, total cholesterol, uric acid levels, and proteinuria than patients without AAS; they also had more severe histological findings, decreased renal function, and lower survival rates than those without AAS (64.0 versus 84.7%, p < 0.001). Multivariate Cox regression analysis incorporating clinical and histological findings and treatments revealed AAS as an independent factor for disease progression (hazard ratio: 2.23, p = 0.010). Participants in the AAS1 group treated with RASI during follow‐up had a significantly higher renal survival rate than those who were not (75.5 versus 44.3%, p = 0.013). In conclusion, AAS was found to be associated with serious clinical, laboratory, and histological findings and poor prognosis. RASI initiated during the follow‐up period was found to improve renal prognosis.


  • Evaluation of appropriate treatment for IgA nephropathy with mild proteinuria and normal renal function

    by Shota Ogura, Takahito Moriyama, Yoei Miyabe, Kazunori Karasawa, Kosaku Nitta

    Background Tonsillectomy and steroid pulse therapy (TSP) for immunoglobulin A nephropathy (IgAN) is frequently employed in many Japanese institutions; however, performing this invasive treatment in patients with mild IgAN is controversial. This study aimed to evaluate the appropriate treatment for IgAN patients with mild proteinuria. Methods In this retrospective cohort analysis, 122 IgAN patients with mild proteinuria (0.5–1.0 g/day) and estimated glomerular filtration rate of ≥ 60 mL/min/1.73 m2 were classified into three groups as follows: patients treated with TSP (n = 32), oral prednisolone (oPSL, n = 33), and conservative therapy (CONS, n = 47). The clinical and histological backgrounds, 5-year remission rates of urinary findings, and 10-year renal survival rates were analyzed. Results The backgrounds were similar among the three groups. The remission rates of hematuria, proteinuria, and both were significantly higher for TSP and oPSL than for CONS; however, they were similar for TSP and oPSL. In the multivariate Cox regression analysis, TSP and oPSL were independent factors for the remission of urinary findings compared with CONS; however, the relapse rates of urinary abnormalities were similar among the three groups. No patient progressed to end-stage renal disease (ESRD) within 10 years. Adverse effects of corticosteroid therapy were significantly more frequent in oPSL than in TSP. Conclusion In IgAN patients with mild proteinuria and stable renal function, similar to oPSL, TSP showed higher remission rates of hematuria and/or proteinuria than CONS, and no case progressed to ESRD regardless of the treatment methods. Therefore, appropriate treatments should be carefully considered for each patient.


  • Long‐term therapeutic effects of multi‐target therapy in a patient with membranous lupus nephritis: An interesting repeat kidney biopsy case

    by Kazunori Karasawa, Tomo Nakakita, Yoei Miyabe, Kenichi Akiyama, Takahito Moriyama, Keiko Uchida, Kosaku Nitta


  • Open Access

    Grading system utilising the total score of Oxford classification for predicting renal prognosis in IgA nephropathy

    by Yoei Miyabe, Kazunori Karasawa, Kenichi Akiyama, Shota Ogura, Tomo Takabe, Naoko Sugiura, Momoko Seki, Yuko Iwabuchi, Norio Hanafusa, Keiko Uchida, et al.

    The Oxford classification of IgA nephropathy (IgAN) can evaluate each MEST-C score individually. We analysed a new grading system that utilised the total MEST-C score in predicting renal prognosis. Altogether, 871 IgAN patients were classified into three groups using the new Oxford classification system (O-grade) that utilised the total MEST-C score (O-grade I: 0–1, II: 2–4, and III: 5–7 points), and the 10-year renal prognosis was analysed. The clinical findings became significantly severer with increasing O-grades, and the renal survival rate by the Kaplan–Meier method was 94.1%, 86.9%, and 74.1% for O-grades I, II, and III, respectively. The hazard ratios (HRs) for O-grades II and III with reference to O-grade I were 2.8 (95% confidence interval [CI] 1.3–6.0) and 6.3 (95% CI 2.7–14.5), respectively. In the multivariate analysis, mean arterial pressure and eGFR, proteinuria at the time of biopsy, treatment of corticosteroids/immunosuppressors, and O-grade (HR 1.63; 95% CI 1.11–2.38) were the independent factors predicting renal prognosis. Among the nine groups classified using the O-grade and Japanese clinical-grade, the renal prognosis had an HR of 15.2 (95% CI 3.5–67) in the severest group. The O-grade classified by the total score of the Oxford classification was associated with renal prognosis.


  • Long-Term Beneficial Effects of Tonsillectomy on Patients with Immunoglobulin A Nephropathy

    by Takahito Moriyama, Kazunori Karasawa, Yoei Miyabe, Kenichi Akiyama, Yuko Iwabuchi, Shota Ogura, Tomo Takabe, Naoko Sugiura, Momoko Seki, Norio Hanafusa, et al.

    Background: Tonsillectomy may treat IgA nephropathy (IgAN) by reducing the levels of galactose-deficient IgA1. Therefore, we aimed to analyze the long-term effects of tonsillectomy on patients with IgAN, as an initial treatment and as a treatment at any time in their lives. Methods: In this retrospective cohort analysis, 1147 patients with IgAN were grouped according to whether they had undergone tonsillectomy at any time, >1 year after renal biopsy (study 1), or within 1 year after renal biopsy (study 2). The patients were propensity-score matched or divided into four groups according to their proteinuria and renal function. The 20-year renal survival rates were evaluated until serum creatinine levels doubled (primary end point) and ESKD occurred (secondary end point). Results: Patients in both studies had similar background characteristics after propensity score matching. In study 1, the renal survival rates for the primary and secondary end points were significantly higher for patients who underwent tonsillectomy at any time or >1 year after renal biopsy compared with those who did not. In study 2, the renal survival rates for the primary and secondary end points were significantly higher for patients who underwent tonsillectomy soon after renal biopsy compared with those who did not (primary end point, 98% versus 69%, P=0.001; secondary end point, 100% versus 75%, P=0.0001). A stratified analysis showed that significant treatment efficacy was observed for patients with proteinuria >1.0 g/d. Multivariate Cox regression analyses showed that tonsillectomy was associated with disease progression (hazard ratio, 0.27; P=0.04). Complications associated with tonsillectomy occurred in 8% of patients. Conclusions: Among patients with IgAN, tonsillectomy at any time of life, or soon after renal biopsy, prevents disease progression, and the procedure is relatively safe.


  • Impact of the number of steroid pulses in tonsillectomy combined with steroid pulse therapy: a nationwide retrospective study in Japan

    by Takahito Moriyama, Hiroshi Kataoka, Kosaku Nitta, Keita Hirano, Keiichi Matsuzaki, Takashi Yasuda, Yoshinari Yasuda, Kentaro Koike, Shoichi Maruyama, Takashi Yokoo, et al.

    Background Steroid pulse therapy with tonsillectomy is known as a major treatment for IgA nephropathy (IgAN). However, its protocol was different among institutions and the effects of varying the number of steroid pulses remain unclear. Methods From a total of 1,174 IgAN patients in a multicenter retrospective cohort analysis in Japan, 195 patients were treated by tonsillectomy combined with corticosteroid. They were divided into four groups based on the number of administered steroid pulses from 0 to three (TSP0-3), and remission of urinary abnormalities and renal survival until 1.5-fold increase in serum creatinine level from baseline were analyzed among the four groups and between TSP1 and TSP3. Results Among the four groups, renal function was relatively good when the estimated glomerular filtration rate was approximately 80–90 mL/min/1.73m2 and proteinuria was relatively mild (< 1.0 g/gCre). The ratio of patients who developed renal dysfunction was < 5% in all groups, and the cumulative renal survival rate by Kaplan–Meier analysis was similar among groups (log-rank test, p = 0.37), despite varying clinical backgrounds and treatments. After adjustment of the background variables between TSP1 and TSP3, the remission rates of urinary abnormalities were similar and the renal survival rate also remained similar (66.8 vs. 85.4%, p = 0.45). Conclusions In patients with mild proteinuria and good renal function, the number of steroid pulses did not affect the renal outcome in steroid pulse therapy with tonsillectomy. The adaptation and protocols, such as the number of steroid pulses, should be determined for each IgAN patient’s background.


  • Open Access

    Validation of the revised Oxford classification for IgA nephropathy considering treatment with corticosteroids/immunosuppressors

    by Takahito Moriyama, Kazunori Karasawa, Yoei Miyabe, Kenichi Akiyama, Shota Ogura, Tomo Takabe, Naoko Sugiura, Momoko Seki, Yuko Iwabuchi, Keiko Uchida, et al.

    The Oxford classification for IgA nephropathy (IgAN) was updated in 2017. We have validated the revised Oxford classification considering treatment with corticosteroids/immunosuppressors. In this retrospective analysis, 871 IgAN patients were enrolled. Patients were divided into two groups, those treated with or without corticosteroids/immunosuppressors. The 20-year renal prognosis up to end-stage renal disease was assessed using the Oxford classification. In all patients, the renal survival rate was 87.5% at 10 years and 72.6% at 20 years. The T score alone was significantly related to renal prognosis in the Kaplan–Meier analysis and multivariate Cox regression analysis. In the non-treatment group (n = 445), E, S, T, and C scores were significantly related to renal survival rates, however, in the treatment group (n = 426), T score alone was significantly related to renal prognosis on Kaplan–Meier analysis, indicating that corticosteroids/immunosuppressors improved renal prognosis in E1, S1, and C1. In patients with E1, S1, or C1, the treatment group showed significantly better renal prognosis than the non-treatment group in univariate and multivariate analysis. The Oxford classification and T score were used to determine renal prognosis in IgAN patients. Corticosteroids/immunosuppressors improved renal prognosis, especially E1, S1, and C1 scores.